CWRU Technology Ventures β Full Portfolio
40 tracked investments Β· listed companies and verified rows first
Lucid Diagnostics develops tests for the early detection of esophageal precancer using targeted next-generation sequencing, aimed at helping clinicians detect and treat the condition before it progresses to cancer.
BiotechDigital HealthHealthtechMedical DevicesLake Forest, US
Michael A Gordon(Executive Officer)Shaun O'Neil(Executive Officer)Lishan Aklog(Chairman & CEO)Dennis McGrath(Executive Officer)Debra White(Director)Stanley Lapidus(Director)
NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair.
BiotechDeep TechHealthtechMedical Devices
Randall Kaye(Director)William Adams(Executive Officer)Brian Bayley(Director)Michael Abrams(Director)Paul Brennan(Director, Executive Officer)Bill Radvak(Director)
Afference develops neurotechnology that enables remote sensory perception through wearable devices, allowing people at a distance to share tactile sensations.
AI & Machine LearningDeep TechHardwareHealthtechCleveland, US
Jacob Segil(Co-founder & CEO)inDustin Tyler(Co-founder & CTO)in
BoardTaylor Hurst(Director)Trevor Zimmerman(Director)
AlensiaXR develops holographic technology that replaces traditional cadavers in medical and dental education.
Deep TechEdTechHealthtech
Mark Day(Chief Executive Officer)in
Atelerix Life Sciences develops novel respiratory therapies for drug-induced respiratory depression, respiratory disease exacerbations, and bio-defense against respiratory threats.
BiotechHealthtechMedical DevicesIndianapolis, US
David Kalergis(Executive Officer, Director, Promoter)William Akridge(Director)Peter Barton Hutt(Director)
BioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods.
BiotechHealthtechMedical DevicesCleveland, US
BIOHM manufactures and sells probiotic supplements and diagnostic gut test kits designed to optimize digestive health.
BiotechDirect to ConsumerWellness & FitnessCleveland, US
Mahmoud Ghannoum(Director)Afif Ghannoum(Director)Sam Schatz(Executive Officer)Steven Himmel(Director)Michael Haritakis(Executive Officer)
BoardBob Pavey(Director)
Amgen is a biopharmaceutical company that develops and manufactures therapeutics targeting oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other serious illnesses.
BiotechDigital HealthHealthtechMedical DevicesThousand Oaks, US
George B. Rathmann(First CEO)
BoardWilliam K. Bowes
Bisc Therapeutics develops Bax inhibitor therapies designed to prevent retinal cell death and preserve vision in patients with retinal degenerative diseases such as age-related macular degeneration, glaucoma, and inherited retinal disorders.
BiotechHealthtech
BoneZone is an online publication covering topics related to medical device manufacturing, including sterilization methods and toxicity testing.
Media & EntertainmentMedical Devices
Convelo Therapeutics develops remyelination-enhancing therapies targeting multiple sclerosis by activating oligodendrocytes to repair nerve damage in the central nervous system.
BiotechDigital HealthHealthtechMedical DevicesCleveland, US
Paul Tesar(Co-founder, Professor)Drew Adams(Co-founder, Professor)Derrick Rossi(CEO)Ronald Richard(Director)Bill Sanford(Director)Steven Landau(Executive Officer)
COSMIIC develops active implantable medical devices, including its Networked Neuroprosthesis (NNP) modular implant platform that stimulates muscles and records signals to restore function for people with disability and disease.
BiotechDeep TechHealthtechMedical DevicesCleveland, US
Edifice Analytics provides software that quantifies energy and cost savings opportunities in commercial buildings using diagnostics, prognostics, and comparative analytics.
CleantechData & InfrastructureEnterprise SoftwareCleveland, US
Dave Gordon(CEO)Alexis Abramson(Co-founder / Senior Technical Advisor)Roger French(Co-founder / CTO)
Medtronic designs and develops medical technology for treating complex diseases.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Folio Photonics develops enterprise-scale immutable active archive storage solutions using photonic materials science to reduce cost and improve security for long-term data retention.
Data & InfrastructureDeep TechHardwareSolon, US
Steven J. Santamaria(Executive Officer, Director)Ronald B. Richard(Director)Robert D. Pavey(Director)Kenneth D. Singer(Executive Officer, Director)Felix Brueck(Director)
Global Health Metrics provides population health analytics and risk assessment tools for health plans, employers, and healthcare providers.
Data & InfrastructureEnterprise SoftwareHealthtech
Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders.
BiotechMedical Devices
Michael Bruckman(CEO)Matthew Neal(CMO)Christa Pawlowski(COO and EVP of R&D)Anirban Sen Gupta(CTO)Timothy Pelura(Executive Chair)
Hemex Health develops and commercializes the Gazelle diagnostic platform, including point-of-care readers and tests for conditions such as sickle cell disease and hemoglobin variants.
Digital HealthHealthtechMedical DevicesPortland, US
Prakash Agarwal(Director)Mohan Uttarwar(Director)Patricia White Seminario(Executive Officer, Director, Promoter)Peter Galen(Chief Innovation Officer, Co-Founder)Susan Morgensztern(Director)Annette Mulee(Director, Promoter)
Light-Handed is developing diagnostic technology to improve the diagnosis of middle ear effusion (MEE), applying biomedical optics to medical device development.
Deep TechHardwareHealthtechMedical Devices
Steven Burns(Chief Executive Officer)Brecken Blackburn(Chief Science Officer)Matt McPheeters(Chief Technology Officer)
BiotechHealthtechMedical DevicesMinneapolis, US
Jeff Liter(Executive Officer, Director, Promoter)James Haymaker(Director, Promoter)David Largaespada(Executive Officer, Director, Promoter)
BoardJeff Ross(Director)John Wells(Director)Tracey Lodie(Director)
MT develops cancer-specific molecular imaging agents (probes) targeting a common oncoprotein in the tumor microenvironment, intended for use with imaging modalities such as CT, PET, MRI, SPECT and ultrasound.
BiotechHealthtechMedical DevicesOhio, US
Audrey Carballo
Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.
BiotechHealthtechMedical DevicesWellington, US
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device for managing chronic phantom limb pain and residual limb pain in adults with lower limb loss.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President, Chief Executive Officer, and Secretary)Zach Stassen(Chief Financial Officer)Claiborne R. Rankin(Director)Robert J. Centa(Chief Financial Officer)Joseph J. Jankowski(Director)Scott F. Drees(Director)
Picture Health develops AI tools that analyze medical imaging to generate quantified biological biomarkers for cancer diagnosis and treatment monitoring.
AI & Machine LearningDigital HealthMedical Devices
Cleveland-based polymeric development company acquired by Peak Nanosystems for $25M in 2020.
BiotechSeattle, US
Asish Xavier(Director)Steve Gillis(Director)Thong Le(Executive Officer, Director, Promoter)David Schubert(Executive Officer, Promoter)Sanford Markowitz(Director)James Sullivan(Director)
Developing an HIV vaccine to allow patients treatment-free latency periods of 12-24 months.
Symphony Robotics develops investigational robotic technology for healthcare applications.
Medical DevicesRobotics
Synapse Biomedical develops and commercializes neurostimulation medical devices, including the NeuRx Diaphragm Pacing System (DPS), which uses electrical stimulation of the diaphragm to treat chronic respiratory insufficiency in patients with spinal cord injuries and ALS.
BiotechDigital HealthHealthtechMedical DevicesHarrisburg, US
Anthony R Ignagni(Executive Officer, Director)Kiyotaka Mori(Director)Moustapha Diop(Chief Operating Officer)Raymond P Onders(Director)John Krystowski(Director)Anthony R. Ignagni(Co-founder, President & CEO)
Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy.
BiotechBoston, US
Harvey LodishDaniel FischerWarren Lammert
Trailhead Biosystems develops HD-DoE (High-Dimensional Design-of-Experiments), a platform that uses computational models and control systems to differentiate human induced pluripotent stem cells (iPSCs) into specific cell types for regenerative medicine and stem cell research.
AI & Machine LearningBiotechDeep TechMedical DevicesBeachwood, US
Jan Jensen(Founder)Joshua Snow(Chief Commercial Officer)Divya Trivedi(Chief Operating Officer and Secretary)David Llewellyn(President & CEO)Magnus Persson(Chairman)Josh Snow(Chief Commercial Officer)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.